M. Hayat - Concepedia

Author

M. Hayat

Also Known As

A. Thyss, M Hayat, M. HAYAT, M. Hayat, MA HAYAT, Maryam Hayat, Meena Hayat, Mian Zain Hayat, Mohammad Hayat, Mudassar Hayat

159

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Institut Gustave Roussy Hôpital Paul-Brousse Inserm European Organisation for Research and Treatment of Cancer Hôtel-Dieu de Paris

About

M. Hayat is an author at Institut Gustave Roussy specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	49	3.6K
2	Health Sciences	14	15	792
3	Natural Sciences	3	3	64
4	Public Health	3	3	305
5	Allergy	1	1	11

M. Hayat

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA G Mathé, Jeanne Amiel, L Schwarzenberg, The Lancet Immunosuppressive TherapyImmunologyHematologyAutoimmunityLymphatic Disease	1969	612
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. Bob Löwenberg, Stefan Suciu, E Archimbaud, Journal of Clinical Oncology	1998	288
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987 M Tubiana, M. Henry‐Amar, Patrice Carde, Blood	1989	261
Adriamycin cardiotoxicity: a survey of 1273 patients. C Praga, G. Beretta, Vigo Pl, PubMed Ecg MonitoringHeart FailureOncologyMedicineAdriamycin Cardiotoxicity	1979	248
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. Patrice Carde, Anton Hagenbeek, M. Hayat, Journal of Clinical Oncology	1993	209
Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum G Mathé, Jeanne Amiel, L Schwarzenberg, BMJ ImmunologyBlood CellPathologyImmunotherapyAplastic Anemia	1970	200
Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomised controlled trial comparing two protocols of dental care B Borowski, E Benhamou, J.L. Pico, European Journal of Cancer Part B Oral Oncology MedicineOral CavityImmunologyOral HygienePreventive Dentistry	1994	175
Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors. Patrice Carde, J M Burgers, M. Henry‐Amar, Journal of Clinical Oncology Prognostic FactorsSurgical OncologyImmunodeficienciesCancer ManagementPathology	1988	168
Pericarditis and myocardial infarctions after Hodgkin's disease therapy Jean‐Marc Cosset, M. Henry‐Amar, B. Pellae-Cosset, International Journal of Radiation OncologyBiologyPhysics Disease TherapyCardiovascular DiseasePericardial DiseasePublic HealthConstrictive Pericarditis	1991	145
A multivariate analysis of prognostic factors in early stage hodgkin's disease M Tubiana, M. Henry‐Amar, B. van der Werf‐Messing, International Journal of Radiation OncologyBiologyPhysics Prognostic FactorsOncologyEarly Stage HodgkinDisease ProgressionMedicine	1985	143

Page 1